Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DONEPEZIL HYDROCHLORIDE (ANHYDROUS), with a corresponding US DMF Number 29182.
Remarkably, this DMF maintains an Active status since its submission on March 18, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 09, 2015, and payment made on April 17, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II